First referral to an integrated onco-palliative care program: a retrospective analysis of its timing

por Barth, Claire, Colombet, Isabelle, Montheil, Vincent, Huillard, Olivier, Boudou-Rouquette, Pascaline, Tlemsani, Camille, Alexandre, Jérôme, Goldwasser, François, Vinant, Pascale
Publicado 2020

Pituitary Lesion of Unknown Origin: Think Epithelioid Angiosarcoma

por Bricaire, Léopoldine, Villa, Chiara, Brière, Mathilde, Edjlali, Myriam, Larousserie, Frédérique, d’Ussel, Marguerite, Bertherat, Jérôme, Boudou-Rouquette, Pascaline, Groussin, Lionel
Publicado 2017

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

por Mir, Olivier, Coriat, Romain, Blanchet, Benoit, Durand, Jean-Philippe, Boudou-Rouquette, Pascaline, Michels, Judith, Ropert, Stanislas, Vidal, Michel, Pol, Stanislas, Chaussade, Stanislas, Goldwasser, François
Publicado 2012

Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options

por Tlemsani, Camille, Larousserie, Frédérique, De Percin, Sixtine, Audard, Virginie, Hadjadj, Djihad, Chen, Jeanne, Biau, David, Anract, Philippe, Terris, Benoit, Goldwasser, François, Pasmant, Eric, Boudou-Rouquette, Pascaline
Publicado 2023

Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

por Noé, Gaëlle, Bellesoeur, Audrey, Golmard, Lisa, Thomas-Schoemann, Audrey, Boudou-Rouquette, Pascaline, Tiako Meyo, Manuela, Puszkiel, Alicja, Arrondeau, Jennifer, Alexandre, Jérome, Goldwasser, François, Blanchet, Benoit, Vidal, Michel
Publicado 2019

Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients

por Minot-This, Marie-Sophie, Boudou-Rouquette, Pascaline, Jouinot, Anne, de Percin, Sixtine, Balakirouchenane, David, Khoudour, Nihel, Tlemsani, Camille, Chauvin, Jonathan, Thomas-Schoemann, Audrey, Goldwasser, François, Blanchet, Benoit, Alexandre, Jérôme
Publicado 2022

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

por Mogenet, Alice, Finetti, Pascal, Denicolai, Emilie, Greillier, Laurent, Boudou-Rouquette, Pascaline, Goldwasser, François, Lumet, Gwenael, Ceccarelli, Michele, Birnbaum, Daniel, Bedognetti, Davide, Mamessier, Emilie, Barlesi, Fabrice, Bertucci, François, Tomasini, Pascale
Publicado 2023

Predicting Frailty and Geriatric Interventions in Older Cancer Patients: Performance of Two Screening Tools for Seven Frailty Definitions—ELCAPA Cohort

por Martinez-Tapia, Claudia, Laurent, Marie, Paillaud, Elena, Caillet, Philippe, Ferrat, Emilie, Lagrange, Jean-Léon, Rwabihama, Jean-Paul, Allain, Mylène, Chahwakilian, Anne, Boudou-Rouquette, Pascaline, Bastuji-Garin, Sylvie, Audureau, Etienne
Publicado 2022

Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment

por Couderc, Anne-Laure, Liuu, Evelyne, Boudou-Rouquette, Pascaline, Poisson, Johanne, Frelaut, Maxime, Montégut, Coline, Mebarki, Soraya, Geiss, Romain, ap Thomas, Zoé, Noret, Aurélien, Pierro, Monica, Baldini, Capucine, Paillaud, Elena, Pamoukdjian, Frédéric
Publicado 2023

A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve Analysis

por González Serrano, Adolfo, Laurent, Marie, Barnay, Thomas, Martínez-Tapia, Claudia, Audureau, Etienne, Boudou-Rouquette, Pascaline, Aparicio, Thomas, Rollot-Trad, Florence, Soubeyran, Pierre, Bellera, Carine, Caillet, Philippe, Paillaud, Elena, Canouï-Poitrine, Florence
Publicado 2023

Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study

por Boudou-Rouquette, Pascaline, Narjoz, Céline, Golmard, Jean Louis, Thomas-Schoemann, Audrey, Mir, Olivier, Taieb, Fabrice, Durand, Jean-Philippe, Coriat, Romain, Dauphin, Alain, Vidal, Michel, Tod, Michel, Loriot, Marie-Anne, Goldwasser, François, Blanchet, Benoit
Publicado 2012

Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab

por Noel, Johanna, Jouinot, Anne, Alexandre, Jérôme, Ulmann, Guillaume, Bretagne, Marie, Castel-Ajgal, Zahra, De Percin, Sixtine, Vaquin-Villeminey, Clémentine, Revel, Marie-Pierre, Peyromaure, Michael, Boudou-Rouquette, Pascaline, Arrondeau, Jennifer, Gataa, Ithar, Durand, Jean-Philippe, Goldwasser, François, Huillard, Olivier
Publicado 2022

Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study

por Subbiah, Vivek, Braña, Irene, Longhi, Alessandra, Boni, Valentina, Delord, Jean-Pierre, Awada, Ahmad, Boudou-Rouquette, Pascaline, Sarantopoulos, John, Shapiro, Geoffrey I., Elias, Anthony, Ratan, Ravin, Fernandez, Cristian, Kahatt, Carmen, Cullell-Young, Martin, Siguero, Mariano, Zeaiter, Ali, Chawla, Sant P.
Publicado 2022

Is there an Exposure–Response Relationship for Nivolumab in Real-World NSCLC Patients?

por Bellesoeur, Audrey, Ollier, Edouard, Allard, Marie, Hirsch, Laure, Boudou-Rouquette, Pascaline, Arrondeau, Jennifer, Thomas-Schoemann, Audrey, Tiako, Manuela, Khoudour, Nihel, Chapron, Jeanne, Giraud, Frédérique, Wislez, Marie, Damotte, Diane, Lupo, Audrey, Vidal, Michel, Alexandre, Jérôme, Goldwasser, François, Tod, Michel, Blanchet, Benoit
Publicado 2019

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

por Tiako Meyo, Manuela, Jouinot, Anne, Giroux-Leprieur, Etienne, Fabre, Elizabeth, Wislez, Marie, Alifano, Marco, Leroy, Karen, Boudou-Rouquette, Pascaline, Tlemsani, Camille, Khoudour, Nihel, Arrondeau, Jennifer, Thomas-Schoemann, Audrey, Blons, Hélène, Mansuet-Lupo, Audrey, Damotte, Diane, Vidal, Michel, Goldwasser, François, Alexandre, Jérôme, Blanchet, Benoit
Publicado 2020

Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients...

por Boudou-Rouquette, Pascaline, Arrondeau, Jennifer, Gervais, Claire, Durand, Jean-Philippe, Fabre, Elizabeth, De Percin, Sixtine, Villeminey, Clémentine Vaquin, Piketty, Anne-Catherine, Rassy, Nathalie, Ulmann, Guillaume, Damotte, Diane, Mansuet-Lupo, Audrey, Giraud, Frédérique, Alifano, Marco, Wislez, Marie, Alexandre, Jérôme, Jouinot, Anne, Goldwasser, François
Publicado 2021

Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers

por Richer, Wilfrid, Masliah-Planchon, Julien, Clement, Nathalie, Jimenez, Irene, Maillot, Laetitia, Gentien, David, Albaud, Benoît, Chemlali, Walid, Galant, Christine, Larousserie, Frederique, Boudou-Rouquette, Pascaline, Leruste, Amaury, Chauvin, Celine, Han, Zhi Yan, Coindre, Jean-Michel, Varlet, Pascale, Freneaux, Paul, Ranchère-Vince, Dominique, Delattre, Olivier, Bourdeaut, Franck
Publicado 2017

Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study

por Duruisseaux, Michaël, Besse, Benjamin, Cadranel, Jacques, Pérol, Maurice, Mennecier, Bertrand, Bigay-Game, Laurence, Descourt, Renaud, Dansin, Eric, Audigier-Valette, Clarisse, Moreau, Lionel, Hureaux, José, Veillon, Remi, Otto, Josiane, Madroszyk-Flandin, Anne, Cortot, Alexis, Guichard, François, Boudou-Rouquette, Pascaline, Langlais, Alexandra, Missy, Pascale, Morin, Franck, Moro-Sibilot, Denis
Publicado 2017

Patterns of care and outcome of CIC‐rearranged sarcoma patients: A nationwide study of the French sarcoma group

por Brahmi, Mehdi, Gaspar, Nathalie, Gantzer, Justine, Toulmonde, Maud, Boudou‐Rouquette, Pascaline, Bompas, emmanuelle, Firmin, Nelly, Valentin, Thibaud, Cancel, Mathilde, Duffaud, Florence, Bertucci, Francois, Perrin, Christophe, Dufresne, Armelle, Marec‐Bérard, Perrine, Jean‐Denis, Myriam, Ray‐Coquard, Isabelle, Le Loarer, Francois, Pierron, Gaille, Tirode, Franck, Blay, Jean‐Yves, Watson, Sarah
Publicado 2022

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

por Damotte, Diane, Warren, Sarah, Arrondeau, Jennifer, Boudou-Rouquette, Pascaline, Mansuet-Lupo, Audrey, Biton, Jérôme, Ouakrim, Hanane, Alifano, Marco, Gervais, Claire, Bellesoeur, Audrey, Kramkimel, Nora, Tlemsani, Camille, Burroni, Barbara, Duche, Angéline, Letourneur, Franck, Si, Han, Halpin, Rebecca, Creasy, Todd, Herbst, Ronald, Ren, Xing, Morel, Pascale, Cesano, Alessandra, Goldwasser, François, Leroy, Karen
Publicado 2019